ArticleThe World Allergy Organization journal2011
Asthma care in resource-poor settings.
Article in The World Allergy Organization journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 22 citations in OpenAlex.
- Pre-COVID era pediatric disease incidence in Kazakhstan: regional panel data analysis of multiple disease groups (2010-2019).Frontiers in public health · 2025Article
- Global Considerations in Asthma Treatment: Management in Low Resource Settings.Advances in experimental medicine and biology · 2023Article
- Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic.Advances in therapy · 2022Article
- The Care of Asthma Patients in Communities with Limited Resources.Research and reports in tropical medicine · 2021Review
- Impact of asthma control on different age groups in five Latin American countries.The World Allergy Organization journal · 2020Article
- Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis.The World Allergy Organization journal · 2018Article
- The epidemiology of noncommunicable respiratory disease in sub-Saharan Africa, the Middle East, and North Africa.Malawi medical journal : the journal of Medical Association of Malawi · 2017Review
- Montelukast for the high impact of asthma exacerbations in Venezuela: a practical and valid approach for Latin America?The World Allergy Organization journal · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asthma prevalence in low- to middle-income countries is at least the same or higher than in rich countries, but with increased severity. Lack of control in these settings is due to various factors such as low accessibility to effective medications, multiple and uncoordinated weak infrastructures of medical services for the management of chronic diseases such as asthma, poor compliance with prescribed therapy, lack of asthma education, and social and cultural factors. There is an urgent requirement for the implementation of better ways to treat asthma in underserved populations, enhancing the access to preventive medications and educational approaches with modern technological methods.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.